2017
DOI: 10.3201/eid2311.170960
|View full text |Cite
|
Sign up to set email alerts
|

Emergence ofBordetella holmesiias a Causative Agent of Whooping Cough, Barcelona, Spain

Abstract: We describe the detection of Bordetella holmesii as a cause of whooping cough in Spain. Prevalence was 3.9% in 2015, doubling to 8.8% in 2016. This emergence raises concern regarding the contribution of B. holmesii to the reemergence of whooping cough and the effectiveness of the pertussis vaccine.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
9
0
4

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 14 publications
1
9
0
4
Order By: Relevance
“…The present genomic study of the genus Bordetella highlights patterns of chromosome structural variation in two species, B. parapertussis and B. holmesii. Although B. pertussis is the primary agent, B. parapertussis also causes clinical whooping cough (18,28,56), and increasing reports have attributed pertussis-like cough illness to B. holmesii (19)(20)(21)(22). Current acellular pertussis vaccines contain immunogenic proteins purified from B. pertussis and provide no cross-protection against B. holmesii (57,58) and debated protection against B. parapertussis (59)(60)(61)(62)(63)(64)(65)(66).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The present genomic study of the genus Bordetella highlights patterns of chromosome structural variation in two species, B. parapertussis and B. holmesii. Although B. pertussis is the primary agent, B. parapertussis also causes clinical whooping cough (18,28,56), and increasing reports have attributed pertussis-like cough illness to B. holmesii (19)(20)(21)(22). Current acellular pertussis vaccines contain immunogenic proteins purified from B. pertussis and provide no cross-protection against B. holmesii (57,58) and debated protection against B. parapertussis (59)(60)(61)(62)(63)(64)(65)(66).…”
Section: Discussionmentioning
confidence: 99%
“…B. holmesii and B. parapertussis cause similar cough illnesses in humans that, while generally regarded as less severe, can be clinically indistinguishable from B. pertussis infection and meet the pertussis clinical case definition (17)(18)(19)(20)(21)(22)(23)(24). Cocirculation and coinfection have been reported with no discernible difference in symptomology between etiologies (23)(24)(25)(26)(27)(28).…”
mentioning
confidence: 99%
“…holmesii in 1.1 to 4.1% of positive samples and B. parapertussis in 0.3 to 8.2% of positive samples (27, 28). In addition, a study in France described a very high prevalence, up to 20%, of B.…”
Section: Discussionmentioning
confidence: 97%
“…Current understanding of the whooping-cough etiology has changed, since it is not restricted to infections exclusively caused by B. pertussis , but embraces also pertussis-like illnesses caused by B. holmesii and B. parapertussis . B. pertussis is still a primary causative agent of whooping-cough, with B. holmesii , emerging as the second, and followed by B. parapertussis [ 10 , 12 , 13 , 28 ]. The relation between B. pertussis and B. holmesii infections remains unknown, but cases of the co-infection have been reported recently.…”
Section: Discussionmentioning
confidence: 99%
“…A limited genetic variability among different strains B. holmesii might indicate a fairly recent adaptation to human hosts [ 6 ]. The relation between B. pertussis and B. holmesii infections remains unknown, but cases of the co-infection have been reported recently [ 10 , 11 , 12 ]. Although the infection rate with B. holmesii is low, ranging initially from < 1% of the diagnosed cases in the US and Canada [ 11 ], up to 20% in France [ 13 ] and 29% in Ohio, USA of patients tested for pertussis [ 12 ].…”
Section: Introductionmentioning
confidence: 99%